These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4206016)

  • 41. Cellular reactivity studies to streptococcal antigens. Migration inhibition studies in patients with streptococcal infections and rheumatic fever.
    Read SE; Fischetti VA; Utermohlen V; Falk RE; Zabriskie JB
    J Clin Invest; 1974 Aug; 54(2):439-50. PubMed ID: 4603169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcus.
    Nevagi RJ; Khalil ZG; Hussein WM; Powell J; Batzloff MR; Capon RJ; Good MF; Skwarczynski M; Toth I
    Acta Biomater; 2018 Oct; 80():278-287. PubMed ID: 30266637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD44 enhances macrophage phagocytosis and plays a protective role in Streptococcus equi subsp. zooepidemicus infection.
    Fu Q; Wei Z; Xiao P; Chen Y; Liu X
    Vet Microbiol; 2017 Jan; 198():121-126. PubMed ID: 28062002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Protective action of non virulent Streptococcus pyogenes (group A) against infection of the mouse by the same strain in a virulent state].
    Wahl R; Drach G; Goichot J
    C R Acad Hebd Seances Acad Sci D; 1968 Jan; 266(4):424-7. PubMed ID: 4969165
    [No Abstract]   [Full Text] [Related]  

  • 45. [Reactivity of rabbits in chronic streptococcal infection].
    Toshkov A; Zhelev V; Shirova L; Obretenova K; Radeva M
    Izv Mikrobiol Inst (Sofiia); 1970; 21():131-41. PubMed ID: 4948932
    [No Abstract]   [Full Text] [Related]  

  • 46. Macrophages and resistance of newborn rats to infection.
    Schuit KE
    J Reticuloendothel Soc; 1981 Nov; 30(5):341-6. PubMed ID: 7033529
    [No Abstract]   [Full Text] [Related]  

  • 47. Fibronectin and age-limited susceptibility to type III, group B Streptococcus.
    Patterson LE; Baker CJ; Rench MA; Edwards MS
    J Infect Dis; 1988 Aug; 158(2):471-4. PubMed ID: 3042880
    [No Abstract]   [Full Text] [Related]  

  • 48. Immune recognition in the streptococcal carditis of mice: the role of macrophages in the generation of heart-reactive lymphocytes.
    Dos Reis GA; Gaspar MI; Barcinski MA
    J Immunol; 1982 Apr; 128(4):1514-21. PubMed ID: 7037950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Group A streptococcal pharyngitis: Immune responses involved in bacterial clearance and GAS-associated immunopathologies.
    Soderholm AT; Barnett TC; Sweet MJ; Walker MJ
    J Leukoc Biol; 2018 Feb; 103(2):193-213. PubMed ID: 28951419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel bacterial resistance mechanism against human group IIA-secreted phospholipase A2: role of Streptococcus pyogenes sortase A.
    Movert E; Wu Y; Lambeau G; Touqui L; Areschoug T
    J Immunol; 2011 Dec; 187(12):6437-46. PubMed ID: 22075700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Annihilating host defense.
    Frank MM
    Nat Med; 2001 Dec; 7(12):1285-6. PubMed ID: 11726964
    [No Abstract]   [Full Text] [Related]  

  • 52. [Streptococcus group A L-form survival in mouse peritoneal macrophages].
    Neustroeva VV; Vul'fovich IuV; Churilova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Dec; (12):45-6. PubMed ID: 6364655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Group A
    Pancholi V
    Microbiol Spectr; 2019 Jan; 7(1):. PubMed ID: 30767846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis.
    Lei B; DeLeo FR; Hoe NP; Graham MR; Mackie SM; Cole RL; Liu M; Hill HR; Low DE; Federle MJ; Scott JR; Musser JM
    Nat Med; 2001 Dec; 7(12):1298-305. PubMed ID: 11726969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of group B streptococcal opsonins by radiolabeled bacterial uptake.
    Allred CD; Shigeoka AO; Hill HR
    J Immunol Methods; 1979; 26(4):355-63. PubMed ID: 379227
    [No Abstract]   [Full Text] [Related]  

  • 56. Factor H-IgG Chimeric Proteins as a Therapeutic Approach against the Gram-Positive Bacterial Pathogen
    Blom AM; Magda M; Kohl L; Shaughnessy J; Lambris JD; Ram S; Ermert D
    J Immunol; 2017 Dec; 199(11):3828-3839. PubMed ID: 29084837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Local Th17/IgA immunity correlate with protection against intranasal infection with Streptococcus pyogenes.
    Mortensen R; Christensen D; Hansen LB; Christensen JP; Andersen P; Dietrich J
    PLoS One; 2017; 12(4):e0175707. PubMed ID: 28414746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemotactic activity of polymorphonuclear leukocytes to Streptococcus pyogenes.
    Tylewska S; Kłosińska-Kita E; Malinowski W
    Zentralbl Bakteriol Orig A; 1978 Sep; 241(3):294-300. PubMed ID: 364883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phagocytosis of sheep erythrocytes by macrophages: a study of the attachment phase by scanning electron microscopy.
    Tizard IR; Holmes WL; Parappally NP
    J Reticuloendothel Soc; 1974 Mar; 15(3):225-31. PubMed ID: 4838132
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunosenescence and its potential modulation: lessons from mouse models.
    Boldizsar F; Mikecz K; Glant TT
    Expert Rev Clin Immunol; 2010 May; 6(3):353-7. PubMed ID: 20441421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.